Wu Yan Biotechnology (688238.SH) disclosed the semi-annual report for 2024, and the company achieved operating revenue of 1.13...
Zheng Tong Finance APP news, Wu Yan Biotechnology (688238.SH) disclosed the semi-annual report for 2024, and the company achieved operating revenue of 0.113 billion yuan, a year-on-year increase of 35%; the net loss attributable to shareholders of the parent company was 0.113 billion yuan, a year-on-year expansion; the non-recurring net loss was 0.119 billion yuan, a year-on-year expansion; basic earnings per share was -0.175 yuan.